JBM Healthcare (02161.HK) saw its stock price surge 5.19% in Tuesday's trading session following the release of its impressive half-year financial results. The healthcare company reported robust performance across key metrics, signaling strong business momentum and shareholder value creation.

According to the company's announcement, JBM Healthcare achieved a revenue of HK$429.6 million for the first half of the year. The firm's gross profit reached HK$253.6 million, indicating a healthy profit margin. Most notably, the company reported a net income of HK$115 million, demonstrating its ability to convert revenue into bottom-line growth effectively.

In a move that likely pleased investors, JBM Healthcare declared an interim dividend of HK9.75 cents per share. This dividend announcement, coupled with the strong financial performance, appears to have fueled investor optimism and contributed to the significant stock price appreciation. The market's positive reaction suggests that investors are confident in the company's financial health and future prospects in the competitive healthcare sector.